The core activity of Floratek Pharma is the discovery and development of new therapeutic active ingredients based on plant ingredients for the treatment of diseases, particularly in the field of cancer and central nervous system diseases. The company uses artificial intelligence and computer-aided models to design and optimize small molecules that specifically influence biological processes, thus offering new treatment options for various diseases.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Development of novel therapeutics for the safe and effective treatment of diseases with a focus on cancer; early preclinical and clinical development of small molecules.
Drug discovery with artificial intelligence
Drug discovery with artificial intelligence and computer-aided modelling to accelerate the discovery, optimization and early development of therapeutics.
Development of plant-based small molecules
Development and synthesis of plant-based small molecules from polyphenol scaffolds to modulate cellular signalling pathways, with a focus on selective cytotoxicity and immunomodulation.
Knowledge
No knowledge articles yet
Once Floratek Pharma SA has claimed this profile, we'll publish editorial articles and case studies here together.